Terms: = Cervical cancer AND CD74, ENSG00000019582, 972, protein 41, Ia-GAMMA, HLADG, DHLAG AND Diagnosis
11 results:
1. Risk of primary urological and genital cancers following incident breast cancer: a Danish population-based cohort study.
Sundbøll J; Farkas DK; Adelborg K; Schapira L; Tamang S; Nørgaard M; Cullen MR; Cronin-Fenton D; Sørensen HT
Breast Cancer Res Treat; 2020 Dec; 184(3):825-837. PubMed ID: 32845432
[TBL] [Abstract] [Full Text] [Related]
2. Prior cervical cytology and high-risk HPV testing results for 311 patients with invasive cervical adenocarcinoma: a multicenter retrospective study from China's largest independent operator of pathology laboratories.
Xie F; Zhang L; Zhao D; Wu X; Wei M; Zhang X; Wu X; Fang H; Xu X; Yang M; Qi D
BMC Infect Dis; 2019 Nov; 19(1):962. PubMed ID: 31711435
[TBL] [Abstract] [Full Text] [Related]
3. Increased risk for depression persists for years among women treated for gynecological cancers - a register-based cohort study with up to 19 years of follow-up.
Horsboel TA; Kjaer SK; Johansen C; Suppli NP; Ammitzbøll G; Frøding LP; Lajer H; Dalton SO
Gynecol Oncol; 2019 Jun; 153(3):625-632. PubMed ID: 30975472
[TBL] [Abstract] [Full Text] [Related]
4. Identification of phosphatidylcholine and lysophosphatidylcholine as novel biomarkers for cervical cancers in a prospective cohort study.
Yin MZ; Tan S; Li X; Hou Y; Cao G; Li K; Kou J; Lou G
Tumour Biol; 2016 Apr; 37(4):5485-92. PubMed ID: 26566624
[TBL] [Abstract] [Full Text] [Related]
5. Development of a Multiplex PCR Test with Automated Genotyping Targeting E7 for Detection of Six High-Risk Human Papillomaviruses.
Paes EF; de Assis AM; Teixeira CS; Aoki FH; Teixeira JC
PLoS One; 2015; 10(6):e0130226. PubMed ID: 26087285
[TBL] [Abstract] [Full Text] [Related]
6. Gene expression changes in residual advanced cervical cancer after radiotherapy: indicators of poor prognosis and radioresistance?
Fu ZC; Wang FM; Cai JM
Med Sci Monit; 2015 May; 21():1276-87. PubMed ID: 25940978
[TBL] [Abstract] [Full Text] [Related]
7. Factors associated with cancer-specific and overall survival among Indigenous and non-Indigenous gynecologic cancer patients in Queensland, Australia: a matched cohort study.
Diaz A; Moore SP; Martin JH; Green AC; Garvey G; Valery PC
Int J Gynecol Cancer; 2015 Mar; 25(3):542-7. PubMed ID: 25700033
[TBL] [Abstract] [Full Text] [Related]
8. Risk of second primary malignancies in women with cervical cancer: a population-based study in Taiwan over a 30-year period.
Chen CY; Lai CH; Lee KD; Huang SH; Dai YM; Chen MC
Gynecol Oncol; 2012 Dec; 127(3):625-30. PubMed ID: 22975362
[TBL] [Abstract] [Full Text] [Related]
9. Risk of CIN2 in women with a pap test without endocervical cells vs. those with a negative pap test with endocervical cells: a cohort study with 4.5 years of follow-up.
Giorgi Rossi P; Baiocchi D; Ciatto S;
Acta Cytol; 2010; 54(3):265-71. PubMed ID: 20518409
[TBL] [Abstract] [Full Text] [Related]
10. Effectiveness of decentralized community-based screening, detection, and treatment of breast cancer in low-income, uninsured women.
Bhaskara A; Altamirano M; Trisal V; Paz IB; Lai LL
Am Surg; 2008 Oct; 74(10):1017-21. PubMed ID: 18942635
[TBL] [Abstract] [Full Text] [Related]
11. Prediction of persistence or recurrence after conization for cervical intraepithelial neoplasia III.
Lu CH; Liu FS; Kuo CJ; Chang CC; Ho ES
Obstet Gynecol; 2006 Apr; 107(4):830-5. PubMed ID: 16582119
[TBL] [Abstract] [Full Text] [Related]
